← Leaderboards
Ronald L Schnaar
Johns Hopkins University
$20,308,382
Attributed
$25,030,324
Total exposure
16
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$40,467,153 · 17
By mechanism
P01$19,693,222 · 4
R01$5,258,972 · 4
K12$4,819,790 · 1
R37$2,824,425 · 1
U19$2,274,556 · 1
T32$1,681,302 · 1
Top collaborators
- Vincent C. Hascall5 shared
- Natasha Elizabeth Zachara5 shared
- Ronald Joseph Midura4 shared
- Carol A. De La Motte3 shared
- Robert J Woods2 shared
- Tong Li1 shared
- Kelley W. Moremen1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Bruce S Bochner$17,391,451
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsLeadPolysaccharidesCellsSignal TransductionIn VitroReceptorStructureBaseMolecularGangliosidesInflammatoryIn VivoMediatingEnzymesGlycobiologyLigandsSialic AcidsFamilyNeuronsSiteMemberCell SurfaceInhibitor/Antagonist
Grant awards (78)
Perfecting tools to define the glycan-protein interactome$454,478
R01 · FY2025 · GM · contact PI
Immersive Training in Glycosciences$954,863
K12 · FY2022 · HL
Human siglec ligands control mast cell and eosinophil mediated inflammation$463,779
U19 · FY2022 · AI · contact PI
Immersive Training in Glycosciences$959,338
K12 · FY2021 · HL
Human siglec ligands control mast cell and eosinophil mediated inflammation$509,970
U19 · FY2021 · AI · contact PI
Ganglioside interactome toolkit$495,977
U01 · FY2021 · CA · contact PI
Immersive Training in Glycosciences$963,685
K12 · FY2020 · HL
Regulation of microglia in Alzheimer's Disease by Siglecs and Siglec ligands$785,544
R56 · FY2020 · AG · contact PI
Human siglec ligands control mast cell and eosinophil mediated inflammation$525,234
U19 · FY2020 · AI · contact PI
Ganglioside interactome toolkit$495,977
U01 · FY2020 · CA · contact PI
Immersive Training in Glycosciences$967,902
K12 · FY2019 · HL
Ganglioside interactome toolkit$495,977
U01 · FY2019 · CA · contact PI
Human siglec ligands control mast cell and eosinophil mediated inflammation$358,696
U19 · FY2019 · AI · contact PI
Immersive Training in Glycosciences$974,002
K12 · FY2018 · HL
Defining the role of keratan sulfate recognition in Alzheimer's Disease progression$776,544
R56 · FY2018 · AG
Human siglec ligands control mast cell and eosinophil mediated inflammation$416,877
U19 · FY2018 · AI · contact PI
Glycobiology of Inflammatory Lung Diseases$2,236,155
P01 · FY2017 · HL · contact PI
Human lung counter-receptors for Siglec-8 and Siglec-9$358,480
P01 · FY2017 · HL · contact PI
Brain gangliosides in learning, memory and neuronal excitability$204,401
R21 · FY2017 · MH · contact PI
Administrative Core$162,350
P01 · FY2017 · HL · contact PI
Glycosciences Skills Development Core$85,089
P01 · FY2017 · HL · contact PI
Glycobiology of Inflammatory Lung Diseases$2,291,264
P01 · FY2016 · HL · contact PI
Human lung counter-receptors for Siglec-8 and Siglec-9$367,861
P01 · FY2016 · HL · contact PI
Brain gangliosides in learning, memory and neuronal excitability$244,563
R21 · FY2016 · MH · contact PI
Administrative Core$166,614
P01 · FY2016 · HL · contact PI
Glycosciences Skills Development Core$87,337
P01 · FY2016 · HL · contact PI
Glycobiology of Inflammatory Lung Diseases$2,143,609
P01 · FY2015 · HL · contact PI
Human lung counter-receptors for Siglec-8 and Siglec-9$366,462
P01 · FY2015 · HL · contact PI
Administrative Core$157,513
P01 · FY2015 · HL · contact PI
Glycosciences Skills Development Core$79,282
P01 · FY2015 · HL · contact PI
Glycobiology of Inflammatory Lung Diseases$2,141,575
P01 · FY2014 · HL · contact PI
Human lung counter-receptors for Siglec-8 and Siglec-9$371,812
P01 · FY2014 · HL · contact PI
Mechanisms in HIV-Tat mediated neurotoxicity$348,059
R01 · FY2014 · NS · contact PI
Administrative Core$156,132
P01 · FY2014 · HL · contact PI
Glycosciences Skills Development Core$81,901
P01 · FY2014 · HL · contact PI
Glycobiology of Inflammatory Lung Diseases$2,058,671
P01 · FY2013 · HL · contact PI
Human lung counter-receptors for Siglec-8 and Siglec-9$350,484
P01 · FY2013 · HL · contact PI
Mechanisms in HIV-Tat mediated neurotoxicity$339,270
R01 · FY2013 · NS · contact PI
Administrative Core$145,858
P01 · FY2013 · HL · contact PI
Glycosciences Skills Development Core$76,742
P01 · FY2013 · HL · contact PI
Glycobiology of Inflammatory Lung Diseases$46,421
P01 · FY2013 · HL · contact PI
Glycobiology of Inflammatory Lung Diseases$2,207,463
P01 · FY2012 · HL · contact PI
Human lung counter-receptors for Siglec-8 and Siglec-9$369,909
P01 · FY2012 · HL · contact PI
Mechanisms in HIV-Tat mediated neurotoxicity$351,575
R01 · FY2012 · NS · contact PI
Targeting Endogenous Inhibitors to Enhance Spinal Axon Regeneration After Injury$351,404
R01 · FY2012 · NS · contact PI
Administrative Core$158,823
P01 · FY2012 · HL · contact PI
Glycosciences Skills Development Core$84,492
P01 · FY2012 · HL · contact PI
Glycobiology of Inflammatory Lung Diseases$2,311,671
P01 · FY2011 · HL · contact PI
Complex Carbohydrates in Neuronal Cell Function$401,800
R37 · FY2011 · NS · contact PI
Human lung counter-receptors for Siglec-8 and Siglec-9$378,549
P01 · FY2011 · HL · contact PI
Targeting Endogenous Inhibitors to Enhance Spinal Axon Regeneration After Injury$351,411
R01 · FY2011 · NS · contact PI
Administrative Core$166,003
P01 · FY2011 · HL · contact PI
Glycosciences Skills Development Core$84,700
P01 · FY2011 · HL · contact PI
Complex Carbohydrates in Neuronal Cell Function$405,900
R37 · FY2010 · NS · contact PI
Targeting Endogenous Inhibitors to Enhance Spinal Axon Regeneration After Injury$360,209
R01 · FY2010 · NS · contact PI
Complex Carbohydrates in Neuronal Cell Function$410,000
R37 · FY2009 · NS · contact PI
Targeting Endogenous Inhibitors to Enhance Spinal Axon Regeneration After Injury$364,042
R01 · FY2009 · NS · contact PI
Targeting Endogenous Inhibitors to Enhance Spinal Axon Regeneration After Injury$95,347
R01 · FY2009 · NS · contact PI
Complex Carbohydrates in Neuronal Cell Function$395,630
R37 · FY2008 · NS · contact PI
Targeting Endogenous Inhibitors to Enhance Spinal Axon Regeneration After Injury$352,677
R01 · FY2008 · NS · contact PI
Complex Carbohydrates in Neuronal Cell Function$429,833
R37 · FY2007 · NS · contact PI
Complex Carbohydrates in Neuronal Cell Function$35,115
R37 · FY2007 · NS · contact PI
Complex Carbohydrates in Neuronal Cell Function$369,209
R37 · FY2006 · NS · contact PI
Complex Carbohydrates in Neuronal Cell Function$376,938
R37 · FY2005 · NS
Pharmacology Training Grant$325,036
T32 · FY2005 · GM
Enhancing axon regeneration by multi-inhibitor blocking$226,856
R21 · FY2005 · NS
COMPLEX CARBOHYDRATES IN NEURONAL CELL FUNCTION$367,875
R01 · FY2004 · NS
PHARMACOLOGY TRAINING GRANT$273,375
T32 · FY2004 · GM
Enhancing axon regeneration by multi-inhibitor blocking$189,047
R21 · FY2004 · NS
COMPLEX CARBOHYDRATES IN NEURONAL CELL FUNCTION$367,875
R01 · FY2003 · NS
PHARMACOLOGY TRAINING GRANT$290,734
T32 · FY2003 · GM
COMPLEX CARBOHYDRATES IN NEURONAL CELL FUNCTION$367,875
R01 · FY2002 · NS
PHARMACOLOGY TRAINING GRANT$277,035
T32 · FY2002 · GM
COMPLEX CARBOHYDRATES IN NEURONAL CELL FUNCTION$367,875
R01 · FY2001 · NS
PHARMACOLOGY TRAINING GRANT$263,004
T32 · FY2001 · GM
COMPLEX CARBOHYDRATES IN NEURONAL CELL FUNCTION$369,000
R01 · FY2000 · NS
PHARMACOLOGY TRAINING GRANT$252,118
T32 · FY2000 · GM
COMPLEX CARBOHYDRATES IN NEURONAL CELL FUNCTION$50,000
R01 · FY2000 · NS